MENU
+Compare
STOK
Stock ticker: NASDAQ
AS OF
Jan 14 closing price
Price
$30.97
Change
+$0.39 (+1.28%)
Capitalization
1.77B

STOK Stoke Therapeutics Forecast, Technical & Fundamental Analysis

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine... Show more

STOK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for STOK with price predictions
Jan 14, 2026

STOK saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for STOK moved out of overbought territory on January 09, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 62 similar instances where the indicator exited the overbought zone. In of the 62 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for STOK moved out of overbought territory on December 09, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on January 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on STOK as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for STOK turned negative on January 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STOK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

STOK moved above its 50-day moving average on January 13, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where STOK advanced for three days, in of 303 cases, the price rose further within the following month. The odds of a continued upward trend are .

STOK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 240 cases where STOK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. STOK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.741) is normal, around the industry mean (27.929). P/E Ratio (45.544) is within average values for comparable stocks, (51.397). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.899). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (8.969) is also within normal values, averaging (329.547).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STOK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
STOK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

STOK is expected to report earnings to rise 9.69% to -71 cents per share on March 11

Stoke Therapeutics STOK Stock Earnings Reports
Q4'25
Est.
$-0.71
Q3'25
Missed
by $0.07
Q2'25
Beat
by $0.10
Q1'25
Beat
by $1.82
Q4'24
Beat
by $0.37
The last earnings report on November 04 showed earnings per share of -64 cents, missing the estimate of -57 cents. With 588.00K shares outstanding, the current market capitalization sits at 1.77B.
A.I. Advisor
published General Information

General Information

a company, which engages in the research and development of treatments for genetic diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
45 Wiggins Avenue
Phone
+1 781 430-8200
Employees
110
Web
https://www.stoketherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PNRCX58.580.87
+1.51%
PGIM Jennison Natural Resources C
SPMPX6.280.05
+0.80%
Invesco SteelPath MLP Alpha Plus R5
HILSX24.610.17
+0.70%
Hartford International Value R4
STSVX15.270.09
+0.59%
BNY Mellon Sm Cp Val I
MERFX17.300.02
+0.12%
The Merger Fund A

STOK and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with QTTB. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
+1.28%
QTTB - STOK
49%
Loosely correlated
+6.82%
NGNE - STOK
46%
Loosely correlated
+10.91%
BCYC - STOK
45%
Loosely correlated
+2.00%
KURA - STOK
44%
Loosely correlated
+1.63%
RGNX - STOK
43%
Loosely correlated
-0.66%
More